According to MarketsandMarketstm, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%. Browse 690 market data Tables and ...

According to MarketsandMarkets™, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%.

Terrestrial Bio has dosed the first patients in a Phase I clinical trial evaluating its patch that delivers GLP-1 therapeutic ...

Raphas, a mass-production platform company specializing in microneedle technology, has teamed up with Japanese electronics ...

BioForge and Panther Life Sciences explain how their partnership is advancing vaccine patch technology and keeping the ...

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe ...

As genetic testing becomes increasingly important in modern healthcare, cytogenetics is emerging as a promising career for ...

Creative Biolabs’ integrated workflow addresses challenges in anti-glycopeptide antibody discovery, including weak ...

Scientists have now traced why the H5N1 bird flu virus that jumped into U.S. dairy herds keeps turning up in cows’ udders and ...

Scientists at ETH Zurich have identified a compound that sharply reduced nerve-cell death in mice engineered to develop ...

Genomics has the potential to revolutionize the diagnosis and management of cancer by offering an unprecedented comprehensive view of the molecular underpinnings of pathology. Computational analysis ...

AI has been used to develop a universal vaccine that could protect against multiple coronaviruses. The successful Phase 1 ...